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INTRODUCTION
Migraine headache (MH) is a common disorder affect-
ing over 324.1 million people worldwide that can seriously 
decrease life quality and work productivity of the patients.1 
It is estimated that in the United States 37 million people 
suffer from MH that is equal to 12% of the total popula-
tion.2 The situation is similar in Europe, where more than 
50% of adults reported at least 1 episode of headache dur-
ing the last year and about 4% of the total population suf-
fers from chronic headache.3 Furthermore, some studies 
indicate that the headache prevalence is increasing dur-
ing the last decades in Europe.3
MH represents also a social and economic burden. 
In the United States, the total cost for MH treatment 
accounts for $13 to $17 billion each year and 112 million 
of missed workdays with an indirect loss of $13 billion.4
Despite its prevalence and debilitating nature, MH 
is still widely undiagnosed and undertreated.4 The first 
approach is usually a combination of pharmacologic treat-
ments (both abortive and preventive drugs) and nonphar-
macologic interventions such as behavioral and lifestyle 
changes.4 Despite all the available conservative options, a 
quite relevant group of MH patients remains refractory 
and does not achieve a satisfactory relief.
The idea to treat MH refractory patients with a surgi-
cal procedure is relatively recent. In 1999, Guyuron first 
described the elimination or improvement of MH in a 
group of cosmetic patients who underwent corrugator 
supercilii muscle resection for forehead rejuvenation sur-
gery. One year later, Guyuron confirmed his hypothesis 
with a retrospective study showing the association between 
corrugator supercilii muscle resection and disappearance 
or reduction in MH symptoms.5
In recent years, further evidences and anatomical stud-
ies were determinant to validate the surgical approach. 
Although the pathophysiology of MH remains a matter 
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Background: Literature from the last decade has shown a correlation between 
resection of the occipital muscles and vessels and relief from migraine and tension-
type headaches.
Methods: The aim of this article was to describe the authors' technique to treat 
occipital migraine, while comparing our approach with the other currently avail-
able surgical options. Relevant anatomical issues and their implications in the 
surgical treatment of occipital migraine have been reviewed. We undertook a mod-
ified version of the currently used method of occipital migraine surgery. Patients 
completed questionnaires before and after surgery, and results were compared.
Results: To identify all trigger points, we used a constellation of symptoms referred 
to by the patient rather than injection of botulinum toxin type A. The entire proce-
dure was carried out under local anesthesia. In most of the patients (56) in whom 
a dilated/aneurysmal occipital artery was found, the procedure was limited to liga-
tion of the occipital artery, with no further undermining of muscles or neurolysis, 
which reduced the invasiveness of the procedure.
Conclusions: The main differences between our procedure and the currently used 
method were that (1) extensive undermining and muscular or nerve resection 
were not necessary and (2) no flap was transposed with the purpose of covering 
isolated nerves. Hence, our method could improve the currently used method, 
while minimizing its invasiveness. (Plast Reconstr Surg Glob Open 2019;7:e2507; doi: 
10.1097/GOX.0000000000002507; Published online 8 November 2019.)
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of discussion, it seems evident that nerve compression in 
some specific areas plays a pivotal role in triggering MH 
episodes. More specifically, 4 main trigger zones have been 
described to be addressed by surgical procedures: frontal 
(site I: supraorbital and supratrochlear nerves), tempo-
ral (site II: zygomatic–temporal branch of the trigeminal 
nerve), endonasal (site III: trigeminal end branches), and 
occipital (site IV: great occipital nerve).6 The auriculotem-
poral nerve and lesser occipital nerve (LON), site V and 
VI, respectively, are also considered relevant trigger sites.6
The aim of this article was to describe the authors' 
technique to treat occipital migraine, while comparing 
our approach with the other currently available surgical 
options. Relevant anatomical issues and their implications 




Sensitive innervation of occipital area is provided by 
the greater occipital nerve (GON), the LON, and the third 
occipital nerve (TON), the compression of which could 
potentially be the anatomical explanation of migraine 
symptoms.7–11
The GON arises from the medial branch of the C2 
dorsal root. It runs toward the occipital region, running 
caudal to the inferior oblique muscle. Then, it crosses 
the semispinalis muscle, where it is possible to identify 
the deepest potential compression point of the nerve. 
According to previous anatomical investigations, GON is 
located 20.13 mm from the midline and 77.38 mm inferior 
from the occipital protuberance.9 The course of the nerve 
superiorly to nuchal line is variable.
Some studies reports that GON arches medially to the 
semispinalis muscle, piercing the fascial plane but this 
course is not constant as some other authors describe 
GON piercing the muscles of the occipital region: the 
semispinalis in the vast majority of cases (90% of cases), 
the inferior oblique, or the trapezius.8,9
Along the course of the GON, at least 6 points of com-
pression can be found, which correspond to possible trig-
gers for occipital migraine symptoms:1 the nerve passage 
through a tight fascial band between the obliquus capitis 
inferior and the semispinalis;2 its entrance into the deep 
fascia underlying the semispinalis or the muscle itself;3,4 
its entrance into the semispinalis capitis and trapezius 
muscles;5 the piercing point of the nerve through the ten-
dinous insertion of the trapezius into the nuchal line;6 the 
close neurovascular relationship between the GON and 
the occipital artery (OA).8–11 Indeed, anatomical studies 
demonstrated that a close relationship between the GON 
and the OA exists in more than 50% of individuals. This 
interaction could be an intertwining type of relationship 
when the artery coils around the nerve (70%) or it could 
be a single cross-type (30%) when the artery intercepts the 
nerve at a single point.11,12
Shimizu et al investigated also the anatomical relation-
ship of the OA with the GON and identified a cross-point 
in proximity of the superior nuchal line where an inden-
tation of the nerve was always present; however, histo-
logical examination failed to reveal any findings of nerve 
degeneration.13
Minor trigger sites in this area are the LON and to the 
third occipital nerve, which can be similarly compressed 
by fascial bands and branches of the OA, they seem to 
be the sources of pain for MH located in the lateral por-
tion of the occipital and in the midportion occipital area, 
respectively.14
Patient Selection
Patients eligible to undergo migraine deactivation sur-
gery had to be diagnosed by a board-certified neurologist 
with migraine without aura with more than 15 days/mo 
of headache, lasting for more than 6 months, or chronic 
tension-type headache with more than 15 days/mo of 
headache, lasting for more than 6 months, or new daily 
persistent headache attacks with more than 15 days/mo of 
headache, lasting for more than 6 months. Cluster head-
ache, episodic tension-type headache, and major psychi-
atric disease were regarded as major contraindications to 
perform the surgery. Furthermore, secondary migraine/
headache as a consequence of other organic patholo-
gies (ie, brain tumor, herniated disk of the neck) had to 
be ruled out through magnetic resonance or computer 
tomography investigations.
We firmly believe that clinical findings and physical 
examination are still the best way to identify trigger points' 
location. Patients with occipital MH typically experienced 
pain starting in the upper neck and occipital region at the 
point of exit of the GON from the semispinalis muscle.15 
Manual compression of this site at the early stages of 
the migraine usually assuaged the pain, whereas at later 
stages, this point became tender. Patients could exhibit 
muscle tightness in the region. In addition, a history of 
whiplash or neck sprain might be present.16 If the patient's 
constellation of symptoms does not clearly indicate a spe-
cific trigger site, some authors suggest single site phased 
injection of botulinum toxin type A or a nerve block.16 
However, a nerve block is only helpful when applied in 
patients who present with MHs at the time of the office 
visit, whereas botulinum toxin administration does not 
automatically exclude the suspected trigger point when 
the main cause of nerve compression is vascular in origin. 
Nerve blocks could be helpful; however, patients should 
be seen in the office during an MH attack.15 Therefore, 
we have never performed botulinum toxin type A injec-
tions neither nerve blocks as diagnostic tool, because it 
is the authors' experience that accurate history and care-
ful physical examination can safely detect patient's trigger 
points. Indeed, even in patients reporting diffuse head-
ache, the simple compression of the tender spot by the fin-
gertip of the surgeon during physical examination could 
usually evoke pain confirming the diagnosis. We only used 
a handheld Doppler during physical examination because 
it proved to be an extremely useful tool in the identifi-
cation of trigger points where the OA was irritating the 
nerve.16 Indeed, a positive Doppler signal at the location 
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of pain identified by the patients strongly corroborated 
the diagnosis.
Surgical Treatment
In accordance to our previously published works,6,18–24  
we performed the occipital decompression with the 
patient prone, under local assisted anesthesia. After 
injecting 40 mL of diluted carbocaine 1% + 40-mL NaCl 
0.9%, and 20-mL sodium bicarbonate 8.4%, 2 horizontal 
occipital scalp incisions of 5 cm in length were performed 
along the superior nuchal line bilaterally, at the location 
of arterial signal detected preoperatively by the handheld 
Doppler (Fig. 1). Underneath the subcutaneous tissue, an 
accurate dissection of occipital, trapezius, splenius capi-
tis, and semispinalis capitis muscles allowed to identify the 
GON and vascular bundle (OA). When we found a dilated 
(or frankly aneurysmatic) OA in close connection with the 
GON (Fig. 2), we ligated the vessel without any other sur-
gical maneuvers except for accurate hemostasis and skin 
closure (Fig. 3). In the remaining cases in which vascular 
compression was not found, we performed a conservative 
neurolysis of the GON and LON where the nerves were 
not isolated circumferentially to prevent complications 
and damages to the nerves as a consequence of reduced 
vascularization and following scar tissue formation. The 
occipital, trapezius, splenius capitis, and semispinalis capi-
tis muscles were undermined along the nerves course 
until their emergence into the subcutaneous tissue. At 
the end of the procedure, after an accurate hemostasis, 
the cutaneous access was sutured with absorbable threads, 
without any drainage. No trichotomy was needed, and the 
scar from the incision will be hidden in the patient's hair. 
The total operative time was no longer than 90 minutes 
for bilateral incisions, but often it was less than 60 min-
utes when the relevant anatomical structures were easily 
identified.
Patients were permitted to resume ordinary activities 
in 1 week and heavy exercise in 3 weeks; they had to medi-
cate every 2 days the surgical wound with betadine and 
could take a shower since the day after surgery. Patients 
were seen after initial recovery, at 1 month, and then every 
3 months for 1 year.
Fig. 1. Arterial signal detected preoperatively by portable Doppler.
Fig. 2. Close intersection of the great occipital nerve (big arrow) 
with the OA (small arrow).
Fig. 3. Ligation of OA (small arrow).
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Patients had to fill a daily headache diary and complete 
MH questionnaires assessing MH parameters following 
surgery. The same questionnaires were given preopera-
tively to assess changes in MH. Minimum follow-up was 
12 months.
RESULTS
We retrospectively reviewed the patients who under-
went migraine deactivation surgery at our institution from 
June 2011 until February 2018; we performed MH decom-
pression surgeries in 168 patients with either frontal, 
occipital, or temporal migraine trigger sites. Among them, 
78 patients suffered from occipital migraine (58 bilateral 
and 20 unilateral).
In 56 patients with occipital migraine, we found a 
dilated OA in close connection with the GON and we 
ligated the vessel without any other surgical maneuvers. 
In 22 patients with occipital migraine, vascular compres-
sion was not found and we adopted a more conventional 
approach based on neurolysis of the GON and LON from 
muscles.
We gathered data from questionnaires completed 
before and after surgery. After a mean follow-up of 21 
months (range: 12–67 months), patients with occipital 
migraine had positive response in 94.9% (86.8% complete 
relief and 8.1% significant improvement), and 5.1% did 
not get any better. As for the 56 patients who underwent 
dilated OA ligation, positive response 95.5% (90% com-
plete relief and 5.5% significant improvement) and 4.5% 
did not get any better. As for the 22 patients who did not 
undergo OA ligation, we observed positive response in 
91% (76% complete relief and 15% significant improve-
ment) of the subjects whereas 9% did not get any better 
(Table 1). Statistical analysis by means of Chi-square test 
did not highlight a significant difference between the out-
comes of the 2 groups.
All the patients without improvement of the symptoms 
after OA ligation (4.5%) who suffered from unilateral 
occipital migraine had complete relief after contralateral 
secondary surgery.
Fourteen patients (8.3%) experienced secondary trig-
ger point emergence following primary migraine surgery. 
Among these, 12 patients had 2 trigger points (10 occipital 
and frontal, 2 occipital and temporal) whereas 2 patients 
had all 3 trigger points.
Adverse Events
Migraine surgery is regarded as a minimally invasive 
procedure; thus, no concerning side effects were reported. 
Minor and transient complications reported were intense 
itching (30%) and temporary anesthesia (mean duration 
34 days) in all patients whereas postoperative infections, 
seromas, or hematomas were not observed. All patients 
who were refractory to surgery did not report worsening 
in their MH at any follow-up. Based on our data collected, 
secondary trigger point emergence following primary 
occipital migraine surgery occurred in 11.5% of patients. 
However, we routinely deactivate the main trigger site 
first, and then a second or third surgery was performed 
at the remaining sites 3 months after each surgery. MH 
recurrence may occur from 1 up to 3 months after sur-
gery; thus, the result may be regarded as permanent only 
after the third postoperative month.6,8,25,26
DISCUSSION
Almost 20 years have passed since Guyuron first intro-
duced the concept of migraine surgery.5 He hypothesized 
that nerve compression at various trigger points was 
the origin of headache symptoms and further investiga-
tions were helpful to confirm his theory.6,8,9,12 Therefore, 
reported surgical treatment of occipital trigger site aimed 
at removing the potential compression points of the GON 
and the LON along their course throughout the semi-
spinalis, the splenius, and the trapezius muscles to the 
subcutaneous tissue of the occipital scalp. According to 
Guyuron et al,9 Lin et al,17 Dash et al,14 and Lee et al,27 
the currently adopted procedure for the treatment of the 
occipital trigger site, undertaken under general anesthe-
sia, relied first on an incision in the occipital scalp fol-
lowed by wide undermining, isolation of the GON from 
the subcutaneous tissue till its piercing point through the 
semispinalis muscle, extensive neurolysis of the GON, and 
ligation of the OA when the neurovascular relation was 
encountered in the subcutaneous tissue. Furthermore, 
a portion of both semispinalis and trapezius muscles, 
respectively, located medial and lateral to the GON, was 
removed. Subsequently, a caudally based subcutaneous 
flap was transposed between the GON and the muscle to 
avoid nerve impingement.
Guyuron et al28 reported a study of 195 patients who 
underwent occipital migraine surgery by semispinalis 
capitis resection and subcutaneous flap transposition to 
decompress the GON. Eighty-two percent of patients (n = 
160) experienced greater than or equal to 50% occipital-
specific MH index reduction, including 52% who experi-
enced occipital-triggered MH elimination. One hundred 
sixty-eight patients (86.2%) observed at least 50% reduc-
tion in the number of migraine days. Migraine frequency 
(mean, 57.4% reduction), duration (mean, 36.9% reduc-
tion), and severity (mean, 58.6% reduction) were each 
significantly decreased postoperatively at the occipital site.
Lin et al17 reported their experience of 9 patients 
treated for occipital migraine by semispinalis capitis resec-
tion and subcutaneous flap transposition to decompress 
the GON. They observed a response rate greater than 
90% and a complete resolution in 2 patients. One patient 
exhibited no response to the surgical intervention. Drug 
doses for headaches were reduced more than 50% in 
Table 1. Gathered Data 
GON and/or LON 
Decompression OAL NTSM
Patients 78 56 22
Positive response 94.9% 95.5% 91%
Complete relief 86.8% 90% 76%
Partial relief 8.1% 5.5% 15%
No response 5.1% 3.5% 9%
NTSM, neurolysis at the trapezius and semispinalis muscles; OAL, OA ligation.
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the remaining patients. The overall efficacy of occipital 
migraine surgery in their study was 88.8%.
Bovim et al29 treated 50 patients with occipital migraine 
by GON neurolysis at the trapezius muscle with a partial 
relief of 8% and no complete relief.
Magnússon et al30 in their study reported 13 occipital 
migraines treated by GON neurolysis at the trapezius mus-
cle and at the semispinalis muscle with 72.2% of partial 
relief and no complete relief.
Larson et al31 in their study of 37 patients with occipi-
tal migraine who underwent semispinalis capitis resection 
and subcutaneous flap transposition to decompress the 
GON observed partial relief in 34.3% of patients and com-
plete relief in 45.5% of patients.
Chmielewski et al7 treated 55 patient by OA ligation 
with 41.8% of partial relief and 38.2% of complete relief, 
and 115 patients by semispinalis capitis resection and sub-
cutaneous flap transposition with 27% of partial relief and 
64.3% of complete relief.
Ducic et al32 reported 190 patients with occipital 
migraine treated by GON neurolysis at the trapezius 
muscle and at the semispinalis muscle furthermore the 
semispinalis capitis muscle resection with 37.1% of partial 
relief and 43.4% of complete relief.
Because the exact location and the structures involved 
in nerve compressions are still a matter of investigation, 
most authors performed personal modifications of the 
Guyuron's technique based on their findings and personal 
belief. The main differences between our procedure and 
the ones described above were that, in most cases, exten-
sive undermining or muscular resection was not necessary 
and no flap was transposed with the purpose of covering 
isolated nerves.18
Based on our experience, the ligation of OA when dilated 
compared with the GON e/or LON neurolysis at the trape-
zius and semispinalis muscle allowed a greater percentage 
of complete relief (90% versus 76%; P > 0.5) with a minor 
percentage of partial relief (5.5% versus 15%; P > 0.5). The 
percentage nonresponse patients after OA ligation resulted 
inferior than the “neurolysis” group (4.5% versus 9%; P > 
0.5). Furthermore, because of 4.5% included only unilat-
eral migraine, after the secondary contralateral surgery the 
percentage of nonresponse patients following OA ligation 
was zero. This finding could be due to anastomosis between 
contralateral vessels, making monolateral ligation ineffec-
tive. However, other factors could be involved and further 
investigations will be necessary to address the optimal surgi-
cal procedure for monolateral migraine.
Our strategy allowed us to achieve the highest rate 
of surgical success when compared with other ones pre-
sented. Furthermore, we did not observe some of the 
minor complication commonly reported in literature as 
incisional cellulitis, transient mild incisional alopecia or 
hair thinning (probably due to the subcutaneous flap har-
vest with the involuntary damage to the hair bulbs), and 
lasting neck stiffness that has a reported incidence rang-
ing from 1% to 5% and might be a consequence of the 
extensive undermining and muscles removal.6,8,18–25
Our more conservative approach was the conse-
quence of our experience and belief that the OA played 
a pivotal role in triggering occipital migraine by com-
pressing the GON in most cases. The success rate of our 
occipital migraine surgery technique suggests that the 
close relationship between artery and nerve was, in most 
cases, essential. Therefore, surgical treatment should 
attempt to remove any possible site of nerve compres-
sion along the OA. In author's experience, this aim 
was achieved by OA ligation without any other surgical 
maneuvers when was dilated (or frankly aneurysmatic) in 
close connection with the GON. Indeed, Shimizu et al13 
reported a constant and close relationship between OA 
and GON nerve. An indentation was always present, and 
the cross-point, although no histological findings, was 
evident. These findings support the hypothesis that the 
cross-point between OA and occipital nerve is an impor-
tant landmark for the surgeon who attempts to relieve 
the compression on the nerve.
CONCLUSIONS
Occipital migraine is a common and debilitating 
condition that can be treated successfully with surgery. 
Its anatomical basis is far from being completely under-
stood but it seems evident that nerve compression in the 
occipital area is the main causative agent. According to 
our experience, a dilated OA was usually responsible for 
nerve compression, mostly the GON. Clinical outcome of 
our surgical procedure based on artery ligation seemed to 
prove the validity of this hypothesis. In addition, we also 
described a minimally invasive approach, thus reducing 
operative time and complication rate.
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